Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trialPaul Kim, Paul M. Garofolo, Taylor J.R. Penke et al.|The Lancet Infectious Diseases|2024Cited by 83
Direct interrogation of the role of H3K9 in metazoan heterochromatin functionTaylor J.R. Penke, Robert J. Duronio|Genes & Development|2016Cited by 80
Direct interrogation of the role of H3K9 in metazoan heterochromatin functionRobert J. Duronio, Taylor J.R. Penke|UNC Libraries|2019Cited by 0